Black Rock Inc. Vor Biopharma Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,247,458 shares of VOR stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,247,458

Previous 2,251,411 0.18%

Holding current value

$2.05 Million

Previous $5.07 Million 5.15%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.8 - $2.85 $7,115 - $11,266	-3,953 Reduced 0.18%	2,247,458 $5.33 Million
Q4 2023 Feb 13, 2024	BUY	$1.66 - $2.63 $239,939 - $380,145	144,542 Added 6.86%	2,251,411 $5.07 Million
Q3 2023 Nov 13, 2023	SELL	$2.1 - $3.35 $121,512 - $193,841	-57,863 Reduced 2.67%	2,106,869 $4.47 Million
Q2 2023 Aug 11, 2023	BUY	$3.09 - $5.33 $5.24 Million - $9.05 Million	1,697,134 Added 362.95%	2,164,732 $6.69 Million
Q1 2023 May 12, 2023	BUY	$4.68 - $6.96 $1.08 Million - $1.6 Million	230,327 Added 97.07%	467,598 $2.52 Million

Q4 2022 Feb 13, 2023	SELL	$3.98 - $7.43 $797,393 - $1.49 Million	-200,350 Reduced 45.78%	237,271 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$4.36 - $5.52 $10,886 - $13,783	-2,497 Reduced 0.57%	437,621 $1.74 Million
Q2 2022 Aug 12, 2022	SELL	$3.89 - $6.44 $3.54 Million - $5.85 Million	-909,127 Reduced 67.38%	440,118 $2.19 Million
Q1 2022 May 12, 2022	SELL	$6.04 - $12.23 $326,655 - $661,422	-54,082 Reduced 3.85%	1,349,245 $8.15 Million
Q4 2021 Feb 10, 2022	BUY	$11.32 - $18.02 $3.09 Million - $4.92 Million	273,289 Added 24.18%	1,403,327 $16.3 Million
Q3 2021 Nov 09, 2021	BUY	$12.24 - $20.38 $4.36 Million - $7.26 Million	356,413 Added 46.07%	1,130,038 $17.7 Million
Q2 2021 Aug 11, 2021	BUY	$18.65 - $38.78 $14.4 Million - $30 Million	773,625 New	773,625 $14.4 Million

Others Institutions Holding VOR

# of Institutions

Shares Held

29M

Call Options Held

1.8K

Put Options Held

100

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $34.6M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account